FloraWorks Latest News

Blog categories
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.

FloraWorks Welcomes Dr. Matthew Roberts as New Chief Operating Officer

FloraWorks is excited to welcome Dr. Matthew Roberts as the new Chief Operating Officer (COO). Dr. Roberts will oversee operations, supply chain management, production, quality assurance, and regulatory affairs.

TruCBN™ Study to Be Unveiled at Prestigious Sleep Conference

In a groundbreaking development, the revolutionary TruCBN™ study will be presented at the prestigious SLEEP meeting, the premier annual meeting for sleep medicine and research professionals.

Discovering the Fountain of Youth for Brain Cells: A Groundbreaking Study by FloraWorks and The Salk Institute

In an unprecedented collaborative effort, FloraWorks and The Salk Institute have unveiled groundbreaking research elucidating the neuroprotective effects of cannabinoids on aging neuronal cells.

The Remarkable Health Benefits of CBN: A Comprehensive Overview

In recent years, the interest in cannabinoids—compounds found in the cannabis plant—has surged, not just among researchers but also within the general populace seeking alternative therapies for various health issues.

Cannabinoid Biotech Leader FloraWorks to Present at Seed Showcase 2024 During J.P. Morgan Healthcare Conference

In a notable development within the biotech industry, FloraWorks, a leading company in cannabinoid research, is set to make a significant presentation at the upcoming Global Cannabinoid Research Society Conference.

Revolutionizing Research with FloraWorks' Paragon: A New Era in Technological Advancement

In the rapidly evolving world of scientific research and technological development, staying ahead of the curve is not just an advantage; it's a necessity. This is where FloraWorks' latest innovation, Paragon, comes into play.
No results found.
There are no results with this criteria. Try changing your search.

Stay ahead in the world of cannabinoid science

Join our exclusive email list for the latest insights and breakthroughs.

By clicking Sign Up you're confirming that you agree with our Terms and Conditions.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.